|

Rice Technologies for Cervical Cancer Screening and Diagnosis

RECRUITINGN/ASponsored by M.D. Anderson Cancer Center
Actively Recruiting
PhaseN/A
SponsorM.D. Anderson Cancer Center
Started2021-03-24
Est. completion2028-03-30
Eligibility
Age25 Years – 49 Years
SexFEMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT05372484

Summary

The study aims to compare the accuracy of the lateral flow test to detect HPV at the POC with commercially available HPV test and to determine the diagnostic accuracy and reliability of a multimodal optical imaging system to detect cervical dysplasia, with the gold reference standard of histopathology.

Eligibility

Age: 25 Years – 49 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

1. 25 - 49 year old women
2. Women with a positive cervical cancer screening test (abnormal cytology, positive VIA and/or positive HPV test)
3. Women with intact cervix
4. Women who are not pregnant and with a negative pregnancy test (within 14 days from the date of enrollment) ) and not currently breastfeeding
5. Willing and capable of providing informed consent

Exclusion Criteria:

1. Women under 25 or over 49 years old
2. Women who have undergone a total hysterectomy (with removal of the cervix)
3. Women who are pregnant or breastfeeding

Conditions2

CancerCervical Cancer

Locations1 site

M D Anderson Cancer Center
Houston, Texas, 77030
Kathleen Schmeler, MD713-854-9150kschmele@mdanderson.org

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.